Abstract:As a key component in combination therapy for acquired immunodeficiency syndrome (AIDS), non-nucleoside reverse transcriptase inhibitors (NNRTIs) have been proven to be an essential way in stopping HIV-1 replication. In the present work, in silico studies were conducted on a series of 119 NNRTIs, including 1-(2-hydroxyethoxymethyl)-6-(phenylthio)thymine (HEPT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives by using the comparative molecular field analysis (CoMFA), comparative molecular similarity indices analysis (CoMSIA), docking simulations and molecular dynamics (MD). The statistical results of the optimal model, the ligand-based CoMSIA one (Q 2 = 0.48, R ncv 2 =0.847, R pre 2 = 0.745) validates its satisfactory predictive capacity both internally and externally. The contour maps, docking and MD results correlate well with each other, drawing conclusions as follows: 1) Compounds with bulky substituents in position-6 of ring A, hydrophobic groups around position- 1, 2, 6 are preferable to the biological activities; 2) Two hydrogen bonds between RT inhibitor and the Tyr 318, Lys 101 residues, respectively, and a π-π bond between the inhibitor and Trp 188 are formed and crucial to the orientation of the active conformation of the molecules; 3) The binding pocket is essentially hydrophobic, which are determined by residues such as Trp 229, Tyr 318, Val 179, Tyr 188 and Val 108, and hydrophobic substituents may bring an improvement to the biological activity; 4) DABO and HEPT derivatives have different structures but take a similar mechanism to inhibit RT. The potency difference between two isomers in HEPTs can be explained by the distinct locations of the 6-naphthylmethyl substituent and the reasons are explained in details. All these results could be employed to alter the structural scaffold in order to develop new HIV-1 RT inhibitors that have an improved biological property. To the best of our knowledge, this is the first report on 3D-QSAR modeling of this series of HEPT and DABO NNRTs. The QSAR model and the information derived, we hope, will be of great help in presenting clear guidelines and accurate activity predictions for newly designed HIV-1 reverse transcriptase (RT) inhibitor.

Q(2) guided conformation selection approach of CoMFA for HIV-1 RT inhibitors

CoMFA and CoMSIA Studies on HIV-1 Attachment Inhibitors.

Docking-based CoMFA and CoMSIA Studies on Naphthyl-Substituted Diarylpyrimidines As NNRTIs.

Receptor- and Ligand-Based 3D-QSAR Study for a Series of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Structure-based Rational Quest for Potential Novel Inhibitors of Human HMG-CoA Reductase by Combining CoMFA 3D QSAR Modeling and Virtual Screening.

CoMFA and CoMSIA 3D-QSAR Studies on Quionolone Caroxylic Acid Derivatives Inhibitors of HIV-1 Integrase

3D-QSAR Studies on DATAs and DAPYs for HIV-RT Inhibitors using CoMFA and CoMSIA Approaches

Comparative Molecular Field Analysis (comfa) and Comparative Molecular Similarity Indices Analysis (comsia) of Thiazolone Derivatives As Hepatitis C Virus NS5B Polymerase Allosteric Inhibitors

3D-QSAR for HIV-1 reverse transcriptase inhibitors

Computational Studies on Tetrahydropyrimidine-2-one HIV-1 Protease Inhibitors: Improving Three-Dimensional Quantitative Structure-Activity Relationship Comparative Molecular Field Analysis Models by Inclusion of Calculated Inhibitor- and Receptor-Based Properties.

3D-Qsar Studies on Glycogen Phosphorylase Inhibitors by Flexible Comparative Molecular Field Analysis

Molecular modeling studies of dihydro-alkyloxy-benzyl-oxopyrimidines (DABOs) as non-nucleoside inhibitors of HIV-1 reverse transcriptase using 3D-QSAR, Topomer CoMFA and molecular docking simulations

Docking, Molecular Dynamics and Quantitative Structure-Activity Relationship Studies for HEPTs and DABOs As HIV-1 Reverse Transcriptase Inhibitors

Pharmacophore Guided 3D‐QSAR CoMFA Analysis of Amino Substituted Nitrogen Heterocycle Ureas As KDR Inhibitors

3D-QSAR Modeling, Surflex Docking and Reverse Docking Studies of Diketo-Acid Derivatives as Potent Integrase/Rnase H Inhibitors

Recent Progress In Comparative Molecular Field Analysis

Three-dimensional QSAR of HPPD inhibitors, PSA inhibitors, and anxiolytic agents: effect of tautomerism on the CoMFA models.

Progress on CoMFA Research

Combined 3D-Qsar Modeling and Molecular Docking Study on Azacycles Ccr5 Antagonists

3D-QSAR study of a series of novel triazole antifungal compounds

Combination of 2D and 3D-QSAR Studies on DAPY and DANA Derivatives As Potent HIV-1 NNRTIs